Brief: Cidara Therapeutics Q3 Operating Expenses USD 88.628 Million
06/11/2025 21:07
Nov 06 (Reuters) - Cidara Therapeutics Q3 EPS USD -3.1. Q3 net income USD -83.233 million Q3 operating income USD -88.628 million
Recent news on Cidara Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Merck Seeks Up To $8 Billion In Us Bond Sale Tied To Cidara Deal - Bloomberg News
Merck rises after Wells Fargo upgrades stock to 'overweight'
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade